跳至主要内容
临床试验/JPRN-UMIN000002261
JPRN-UMIN000002261已完成未知

Evaluation of combination therapy with Statin and Ezetimible for patients with type II diabetes. - Evaluation of combination therapy with Statin and Ezetimible

Department of Cardiovascular Medicine, Saga University0 个研究点目标入组 30 人开始时间: 2009年7月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pregnant and/or breathfeeding, child-bearing potential women during this study. 2) Past history of severe allergic reactions to ezetimibe 3) Renal dysfunctioned. (ALT>2 x Normal range of each institute) 4) Uncontrolled diabetes mellitus (HbA1c>=9%) 5) Renal insufficiency (serum creatinine>2.0mg/dL) 6) Heart failure, cardiac infarct, unstable angina, or stroke whithin 3 months. 7) Recieving insulin therapy 8) Secondary hyperlipidemia and/or drug-induced hyperlipidemia 9) Familial hyperlipidemia 10) otherwise, treating physician judged not to be appropriate for inclusion in this study.

研究者

发起方
Department of Cardiovascular Medicine, Saga University

相似试验